22 May 2013
Keywords: gsk, paxil, first, ssri, anxiety, disorder, glaxosmithkline
Article | 17 April 2001
GlaxoSmithKline has been granted approval in the USA to market itsselective serotonin reuptake inhibitor Paxil (paroxetine) for the
treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 April 2001
18 April 2001
19 April 2001
© 2013 thepharmaletter.com